Monitoring systemic lupus erythematosus (SLE) requires comprehensive assessment\ud
of disease activity, comorbidities, chronic damage and patients’ perspective of the\ud
disease. This narrative review summarizes the innovative and currently available tools\ud
to assess SLE patients in clinical research and routine practice setting focusing on what\ud
is new in the assessment of disease activity and damage, discussing composite indices\ud
and organ-specific scores; a separate section is dedicated to the imaging techniques\ud
useful to assess neuropsychiatric, musculoskeletal and renal involvement. SLE-related\ud
chronic damage and comorbid conditions contributing to patients’ illness and longterm\ud
outcome are discussed. Finally, the impact of SLE on patients’ quality of life is\ud
addressed focusing on self-reported questionnaires, adherence to treatment and\ud
work ability